source
- FDA approves first generic single-dose baloxavir tablet for flu treatment and preventionFDA announced approval of the first generic version of Xofluza (baloxavir marboxil) tablets, a single-dose treatment for acute uncomplicated influenza and prophylaxis for patients five years of age…
- Neumora ends development of navacaprant after failed Phase 3 depression trials; EnGene cuts half its workforceNeumora Therapeutics announced it will discontinue its kappa opioid receptor antagonist navacaprant after the drug missed its primary endpoints in two Phase 3 studies for major depressive disorder.…